Chronobiotics

Melatonin and melatonergic drugs on sleep: possible mechanisms of action.

Promoting adjustment of the sleep-wake cycle by chronobiotics

Comparison of agomelatine and escitalopram on nighttime sleep and daytime condition and efficacy in major depressive disorder patients.

Melatonin in Alzheimer's disease and other neurodegenerative disorders

Major depressive disorder, anhedonia and agomelatine: an open-label study.

Melatonin agonists and insomnia.

The use of chronobiotics in the resynchronization of the sleep-wake cycle.

Pharmacological approach to desychronization of the sleep-wakefulness cycle in the military and sport environment

Melatonin as a chronobiotic.

Efficacy and tolerability of ramelteon in a double-blind, placebo-controlled, crossover study in Japanese patients with chronic primary insomnia.

Clinical perspectives for the use of melatonin as a chronobiotic and cytoprotective agent.

Melatonin: circadian rhythm regulator, chronobiotic, antioxidant and beyond.

Photoimmunomodulation and melatonin

Placebo-controlled pilot study of ramelteon for adiposity and lipids in patients with schizophrenia.

Ramelteon prior to a short evening nap impairs neurobehavioral performance for up to 12 hours after awakening.

A benefit-risk assessment of agomelatine in the treatment of major depression.

 

Genetic suppression of the circadian Clock mutation by the melatonin biosynthesis pathway

The emerging modern face of mood disorders: a didactic editorial with a detailed presentation of data and definitions

University of Surrey, Chronobiology Researchers

The Dana Foundation: Researchers Take Another Jab at Jet Lag

Drug Insight: the use of melatonergic agonists for the treatment of insomnia-focus on ramelteon.

Human circadian rhythms: physiological and therapeutic relevance of light and melatonin.